ArticleEMPIRICAL VERSUS SUSCEPTIBILITY-BASED ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN EGYPT
ArticleEMPIRICAL VERSUS SUSCEPTIBILITY-BASED ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN EGYPT
ArticlePrevalence of Helicobacter Pylori in Dyspeptic Patients and Outcome of Load Regimen on its Eradication
ArticlePrevalence of Helicobacter Pylori in Dyspeptic Patients and Outcome of Load Regimen on its Eradication
ArticleEffectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients
ArticleEffectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients
ArticleTreatment of Helicobacter pylori in the Arab world: a systematic review and network meta-analysis
ArticleTreatment of Helicobacter pylori in the Arab world: a systematic review and network meta-analysis
ArticleLevofloxacin versus Clarithromycin-based Therapy for Eradication of Helicobacter Pylori Infection: A Comparative Study
ArticleLevofloxacin versus Clarithromycin-based Therapy for Eradication of Helicobacter Pylori Infection: A Comparative Study
ArticleEfficacy of Vonoprazan-based triple therapy for cure of <i>H. Pylori</i> Infection among patients attending GIT outpatient clinic at Suez Canal University Hospital
ArticleEfficacy of Vonoprazan-based triple therapy for cure of <i>H. Pylori</i> Infection among patients attending GIT outpatient clinic at Suez Canal University Hospital
ArticleHelicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy
ArticleHelicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy
ArticleA Two-Week Nitazoxanide-Based Quadruple Treatment as a Rescue Therapy for Helicobacter Pylori Eradication
ArticleA Two-Week Nitazoxanide-Based Quadruple Treatment as a Rescue Therapy for Helicobacter Pylori Eradication
ArticleA Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Infection in Dyspeptic Patients
ArticleA Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Infection in Dyspeptic Patients